SpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
STAMFORD, Conn., Jan. 03, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe […]